Abstract:
A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root, ligusticum chuanxiong, radix paeoniae lactiflorae, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell, corydalis tuber, and asarum, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.

Description:
FIELD OF THE INVENTION 
       [0001]    The present invention relates to the field of Traditional Chinese medicine (TCM). More specifically, the invention relates to pharmaceutical composition for treating headache, preparative method and its use thereof. 
       BACKGROUND OF THE INVENTION 
       [0002]    Headache is a common symptom in daily life. Almost everyone will have headache in lifetime. The causes of headache are varied. By now, there are a lot of drugs for treating headache abroad or in China, most of which, however, focus on symptomatic treatment of stopping ache (in very few cases, headache is treated by surgery). The results are not satisfactory, because the drugs focus on symptomatic treatment rather than root cause. As a result of this, headache attacks patients recurrently. Long-term use of analgesic agents may cause drug resistance and addiction, so the drug of this kind should not be used for long time. Yet, the headache cannot be cured radically. Besides, according to conditions with different causes, there are different sorts of drugs applied clinically, e.g. the anti-anxiety agent, anti-depressant agent, sympathetic inhibitor, calcium channel blockers and antiepileptic agents etc. Due to their severe side effects, long-term administration will make their efficacy reduced so much that the patients have to increase dose of drug gradually. The result, however, is not satisfactory. The more drugs they take, the severer the headache is. Now, Zhengtian pill (Zhengtianwan) is a Traditional Chinese medicine (TCM) whose formula comprises both TCM and chemical drug. The TCM works by a mechanism of activating blood by removing stasis and the chemical drug stopping pain. In practice, its curative effect is not definite to achieve the purpose of curing radically. Now, there are a lot of TCMs for treating headache. But most of them take effect more slowly; and this drawback will influence life quality of the patients. 
         [0003]    Chinese Patent (No. ZL 93100050.5) disclosed a medicinal composition comprising 11 TCMs of  Radix Angelicae Sinensis  (Dang gui) and  Rhizoma Chuanxiong  (Chuan xiong),  Radix Paeoniae alba  (Bai shao),  Radix Rehmanniae Preparata  (Shu dihuang),  Ramulus Uncariae cum Uncis  (Gou teng),  Caulis Spatholobi  (Ji Xueteng),  Spica Prunellae  (Xia Kucao),  Semen Cassiae  (Jue mingzi),  Concha Margaritifera Usta  (Zhen zhumu),  Rhizoma Corydalis  (Yuan hu) and  Asarum herb  (Xi xin). It is the fruits of long-term clinical practice under the guidance of Chinese medicine theory, having the therapeutic effects of treating headache caused by inner damage. Clinically, it can be applied to treat several headache diseases, such as the angioneurotic headache, migraine, and some symptoms like dizziness and headache etc. caused by hypertension. According to the proportion of this recipe, the granule of this composition is produced by Tasly Pharmaceutical Group Co. Ltd., named as “Yang Xue Qing Nao Granule”. The functions and indications approved by the authorities are nourishing blood and calming liver, activating blood and removing obstruction in channels, used for diverse types of headache elicited by blood deficiency and hyperactivity of liver, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritation, insomnia and dreaminess. In clinic, it has been usually used for treatment headache caused by blood deficiency, blood stasis, and deficiency of Yin and hyperactivity of Yang. Since coming into the market, Yang Xue Qing Nao Granule has gained wide popularity among the patients due to its reassured therapeutic effects. 
         [0004]    Now, it has been literarily reported that the Yang Xue Qing Nao Granule is usually prepared by the following method. The 11 TCMs are extracted with water, which is precipitated with ethanol to give the extract, and then the extract is mixed with excipients to prepare into various kinds of pharmaceutical formulations. For example, Chinese patents (No. 03140844.3, 200410019825.4) disclosed a process that the 11 TCMs were mixed in proportion, extracted with water for 3 times, combined to get an extract after appropriate concentration, which was added with 2 fold of ethanol to leave it to stand still for 24 hours to precipitate to get supernatant. The supernatant was concentrated to an extract with relative density of 1.3˜1.4. The yield rate was 10%. Aforesaid extract was mixed with sucrose and dextrin in a proportion of 1:3:1 to make granule. 
         [0005]    However, due to the different nature of each TCM, the extraction of active ingredients by using method of extracting all together usually results in the extraction incomplete or raises the defect of low yield rate. For example, main ingredients of  Radix Angelicae Sinensis  (Dang gui) and  Rhizoma Chuanxiong  (Chuan xiong) are ethanol soluble, so the ethanol was better. In the same manner, the  Ramulus Uncariae cum Uncis  contains a variety of indole alkaloids, which is dominated by rhynchophylline and isorhynchophylline and a small amount of flavone constituents. Its water decoction and extract are proved to have significantly bio-active effects of sedation, analgesia and antihypertension. Thus, the extraction by water is a more suitable. 
         [0006]    As shown in Chinese patents (200510073290.3 and 200510014828.3), 11 TCMs were disclosed, in which  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae alba  and  Rhizoma Corydalis  were refluxed with ethanol to have a refluxing solution, the residue was mixed with the other 6 TCMs (excluding  Ramulus Uncariae cum Uncis ) including  Radix Rehmanniae Preparata  etc. and extracted with water for 3 times. During the process of 3 rd  decoction, the  Ramulus Uncariae cum Uncis  was added, and the extraction liquid was combined to concentrate in vacuum. Ethanol was used to precipitate and the obtained solution was left standing still. After being filtered, the filtrate was mixed with aforesaid refluxing solution, and ethanol was recovered under reduced pressure, concentrated and dried to obtain the extract. 
         [0007]    In practice, however, extracting  Radix Paeoniae alba  combined with other TCMs will result in the final extract somewhat less in melting ability. Later addition of the  Ramulus Uncariae cum Uncis  into the extract may get the medicine float on the surface, so as to influence the extraction. Not only that, but the operation is complicated with the risk of dangerous steam. Extraction of  Semen Cassiae  by water is prone to cause problems of paste extracting tank or difficult draining 
         [0008]    In view of aforesaid problems, after repeated experimental researches, a new preparation method and a medicinal composition made by this new method have been developed. 
     
    
     DETAILED DESCRIPTION OF THE INVENTION 
       [0009]    The objective of present invention is to provide a pharmaceutical composition for treating headache. 
         [0010]    Another objective of present invention is to provide a preparing method of said composition. 
         [0011]    Another objective of present invention is to provide a use of said composition in preparation of drugs for treating headache, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess, 
         [0012]    The composition of present invention comprises: 4-9 weight parts of  Radix Angelicae Sinensis,  4-9 weight parts of  Rhizoma Chuanxiong,  2-8 weight parts of  Radix Paeoniae alba,  2-8 weight parts of  Radix Rehmanniae Preparata,  10-15 weight parts of  Ramulus Uncariae cum Uncis,  10-15 weight parts of  Caulis Spatholobi,  10-15 weight parts of  Spica Prunellae,  10-15 weight parts of  Semen Cassiae,  10-15 weight parts of  Concha Margaritifera Usta,  4-9 weight parts of  Rhizoma Corydalis  and 0.5-2 weight parts of  Herba Asari.  Said composition is prepared by a method as follows: 
         [0013]    a). Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  are mixed, extracted by using heating refluxing with ethanol, and filtered to remove impurities; and the ethanol is recovered and concentrated to give #1 Extract for later use; 
         [0014]    b). Preparation of #2 Extract:  Radix Paeoniae alba  is extracted by using heating refluxing with ethanol, and filtered; and the ethanol is recovered and concentrated to give #2 Extract for later use; 
         [0015]    c). Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  are mixed, decocted with water, filtered, concentrated, into which ethanol is added to leave it to stand still, and filtered; and the ethanol is recovered and concentrated to give #3 Extract for later use; 
         [0016]    d). Preparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried and granulated to obtain the final product. 
         [0017]    Preferably, said composition of present invention is prepared by a method as follows: 
         [0018]    a). Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  are mixed, extracted by using heating refluxing with 3-6 fold of 50˜80% ethanol for 2-3 times, the first time for 0.5˜2.5 hours; the second and/or third time for 0.5˜2 hours, and filtered to remove the impurities; and the ethanol is recovered and concentrated until the relative density is 1.250˜1.350 (70˜80° C.) to give #1 Extract for later use; 
         [0019]    b). Preparation of #2 Extract:  Radix Paeoniae alba  is added with 3˜6 fold of 50˜80% ethanol, soaked, extracted by using heating refluxing for 2˜3 times, the first time for 0.5˜2.5 hours, the second and/or third time for 0.5˜2 hours, and filtered; and the ethanol is recovered and concentrated until the relative density is 1.10˜1.35 (55˜65° C.) to give #2 Extract for later use; 
         [0020]    c). Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  are combined, decocted with 4˜10 fold of water for 2˜3 times, the first time for 0.5˜3 hours, the second and/or third time for 1˜3 hours, filtered, concentrated until the relative density is 1.06˜1.10 (75˜85° C.), into which ethanol is added to make a final ethanol content of 60˜85%, left to stand still for 12˜24 hours, and filtered; and the ethanol is recovered and concentrated until the relative density is 1.270˜1.350 (75˜85° C.) to give #3 Extract for later use; 
         [0021]    d). Preparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product. 
         [0022]    More preferably, said composition of present invention is prepared by a method as follows: 
         [0023]    a). Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  are mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% ethanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol is recovered and concentrated until the relative density is 1.300˜1.310 (74˜76° C.) to give #1 Extract for later use; 
         [0024]    b). Preparation of #2 Extract:  Radix Paeoniae alba  is added with 4 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the ethanol is recovered and concentrated until the relative density is 1.23˜1.33 (65° C.) to give #2 Extract for later use; 
         [0025]    c). Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  are mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density is 1.06˜1.10 (80° C.), into which ethanol is added to make a final ethanol content of 65˜70%, left to stand still for 12˜24 hours, and filtered; and the ethanol is recovered and concentrated until the relative density is 1.320˜1.325 (79˜81° C.) to give #3 Extract for later use; 
         [0026]    d). Preparation of formulations: aforesaid three Extracts are added with appropriate amount of excipients, dried, granulated to obtain the final product. 
         [0027]    Wherein, said excipients in step d) include one or more kinds of filling agent and flavoring agent. 
         [0028]    Said filling agent is selected from one or more kinds of cellulose, starch, soluble starch, sugar powder, dextrin, mannitol, sucrose, lactose and microcrystalline cellulose, etc. 
         [0029]    Said flavoring agent is selected from one or more kinds of steviosin, aspartame, glycerol, saccharin sodium, sorbitol, mannitol, xylitol, high fructose and sodium cyclamate. 
         [0030]    Preferably, said filling agent is selected from dextrin, starch, soluble starch, sucrose, lactose and microcrystalline cellulose, and said flavoring agent is selected from steviosin and aspartame. 
         [0031]    Most preferably, said filling agent is selected from dextrin and flavoring agent is selected from steviosin. 
         [0032]    In one embodiment, the ratio of aforesaid three Extracts prepared by  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae alba, Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydalis  and  Herba Asari  to the excipients is 40:60 to 65:35 by weight percentage. 
         [0033]    In another embodiment, the ratio of aforesaid three Extracts prepared by  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae alba, Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Semen Cassiae, Concha Margaritifera Usta, Rhizoma Corydalis  and  Herba Asari  to the excipients is 55:45 to 65:35 by weight percentage. 
         [0034]    Wherein, aforesaid ratio is a ratio of the dried extractum converted from aforesaid three Extracts to the excipients. 
         [0035]    According to present invention, said pharmaceutical composition can be prepared into any one of pharmaceutically acceptable oral formulations, including, but not limited to, granules, tablets and capsules, etc, preferably the granules. 
         [0036]    According to present invention, said formulation may be prepared by any one of pharmaceutically acceptable methods, e.g. spray drying granulation method, fluidized-bed spray granulation method, wetting granulation method, dry granulation method and rolling granulation method. 
         [0037]    Preferably, said formulation may be prepared by the fluidized-bed spray granulation method. 
         [0038]    According to present invention, said fluidized-bed spray granulation method comprises following steps: taking a part of filling agent, dissolving it with purified water, adding flavoring agent to dissolve by well-stirring to give slurry; adding well-prepared three Extracts into aforesaid slurry stepwise, stirring, adjusting density of the slurry, online filtering; putting the rest of filling agent into a granulator; performing spray granulation by adjusting granulating parameters; drying; granulating with a sieve; mixing totally and packaging to have the final product. 
         [0039]    Wherein, the addition amount of said flavoring agent accounts for 0˜1% by weight of the total filling agent. The ratio between the part of filling agent firstly added and the rest of the filling agent is 1:4 to 1.5:1 by weight percentage. 
         [0040]    According to present invention, said pharmaceutical composition may be prepared into appropriate package specification, which depends on its various dosage forms, e.g. for the granules, the specification can be selected from 3 g/bag or 4 g/bag. 
         [0041]    According to Present Invention, Extracting Method of Said Pharmaceutical Composition is Obtained by Following Screening Experiments. 
         [0042]    1. The reason why to extract 11 TCMs respectively 
         [0043]    The main ingredients of  Radix Angelicae Sinensis  include: ferulic acid, capable of inhibiting blood coagulation and thrombus formation; water-soluble vitamin B 12 , folic acid, folinic acid and nicotinic acid, capable of promoting generation of erythrocyte and hemoglobin significantly; and angelica polysaccharide, capable of facilitating growth of WBC reticular cell in mice and resisting anemia. 
         [0044]    The main ingredients of  Rhizoma Chuanxiong  include special smell volatile oil-like alkaloids, ferulic acid and volatile oil, etc. The alcohol extract of the  Rhizoma Chuanxiong  has effects of dilating coronary artery, increasing coronary blood flow, protecting myocardium against ischemia, reducing blood pressure significantly, anticoagulation and anti-thrombus, etc. Besides, the tetramethylpyrazine therein is capable of sedation, dilating blood vascular, protecting myocardium against ischemia, as well as reducing blood pressure, anticoagulation and anti-thrombus, etc. The main bioactive ingredients are ethanol soluble in both  Rhizoma Chuanxiong  and  Radix Angelicae Sinensis,  so ethanol extraction is used. 
         [0045]      Radix Paeoniae alba  mainly contains a number of glycosides such as paeoniflorin, as well as volatile oil, tannins and sugar. Its total glycosides are proven to have effects of anti-inflammation, immune regulation, protecting liver, sedation and analgesia, etc. Among them, the paeoniflorin is at the highest concentration, which is easily extracted with ethanol or hot water due to its ester structure. As a result, the extract by ethanol solution is more stable. 
         [0046]    The main ingredients of  Rhizoma Corydalis  are numerous alkaloids, among which the tetrahydropalmatine, corydaline, corydalis L and dehydrocorydaline are proven to have the stronger biological functions, capable of significantly sedating, hypnotizing, reducing coronary resistance and increasing blood flow, etc. All of  Rhizoma Corydalis &#39; ethanol extract, vinegar extract and water extract are found to have effect of relieving pain, and the ethanol one has the best effect among others. At the same time, they have certain of central sedation effect. Its alkaloid is mainly composed of quarternary amine alkali and tertiary amine alkali; the former is water soluble and extracted with water. Both, however, can be extracted with ethanol solution and the yield rate is high. 
         [0047]      Semen Cassiae  contains a series of ingredients of physcion, chrysophanol, emodin, rhein and  Semen Cassiae  lactone. Thus, extraction-by-ethanol is reasonable. 
         [0048]      Ramulus Uncariae cum Uncis  mainly contains various types of indole alkaloids, dominated by rhynchophylline and isorhynchophylline, as well as a little flavonoid. Both its water decoction and extract have marked effects of sedation, relieving pain and reducing blood pressure. Therefore, extraction-by-water is reasonable. 
         [0049]    For the rest in this pharmaceutical composition,  Radix Rehmanniae Preparata, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  work as adjuvant drugs and courier drugs in this formula. The chemical ingredients contained therein include alcohols, amino acids, sterols, anthraquinones, many kinds of sugars and a variety of essential trace elements such as Fe. The water decoction thereof is found to have blood-enriching effect of increasing RBC count, having hemoglobin increased, reducing blood sugar, reducing blood pressure and lowering blood lipid, etc. As a result, according to the requirements of formula and quality of bioactive ingredients, the water-extracting-alcohol-precipitating method is used to extract the bioactive ingredients. 
         [0050]    On the basis of aforesaid analysis, the extraction-by-ethanol method is applied to the medicines of  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Paeoniae alba, Rhizoma Corydalis  and  Semen Cassiae;  the water-extracting-alcohol-precipitating method to  Radix Rehmanniae Preparata, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari.    
         [0051]    2. Investigation of extracting  Radix Paeoniae alba  alone or in combination 
         [0052]      Radix Paeoniae alba  is the main drug in the formula, whose main bioactive ingredient, paeoniflorin, acts as a determination indicator. The yield rate, paeoniflorin content and dissolvability were used as the indicators for investigation of extracting  Radix Paeoniae alba  alone or in combination. Production processes were designed respectively, wherein the 1 st  process included the steps of taking  Radix Paeoniae alba  at prescription dose, into which 5 fold of 70% ethanol was added to extract by refluxing twice, 2 hours for each time; and the 2 nd  process included the steps of taking  Radix Paeoniae alba, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  at prescription dose, into which 5 fold of 70% ethanol was added to extract by refluxing twice, 2 hours for each time. Resultant extracts were combined respectively, appropriate quantity of the extracts (approximately equal to 0.03 g crude medicine of  Radix Paeoniae alba ) were sucked, ethanol was added to a constant volume of 20 ml, and filtered to get the liquid as the sample solution. The rest of the extracts was dried to investigate their yield rate, paeoniflorin content and dissolvability. 
         [0053]    Method for Determination of Paeoniflorin 
         [0054]    Apparatus and Reagent 
         [0055]    Agilent 1100 HPLC was equipped with quaternary pump, DAD, automatic sampler, online degasser and column thermostat. 
         [0056]    Standard paeoniflorin (obtained from China Pharmaceutical Biological Products Analysis Institute), methanol (chromatographically pure), purified water, isopropanol, citric acid (analytically pure) 
         [0057]    Chromatographic conditions: Agilent Zorbax SB-C 18  column (250 mm×4.6 mm, 5 μm) 
         [0058]    Mobile phase: isopropanol-methanol-5% citric acid solution (2:18:80) 
         [0059]    Flow rate: 1.0 ml/min; column temperature: 30° C.; detection wavelength: 240 nm 
         [0060]    Preparation of testing solution: as mentioned before. 
         [0061]    Preparation of standard solution: appropriate quantity of standard paeoniflorin was taken and weighed accurately to prepare the standard solution (with lml solution containing 0.015 mg solute) by adding 80% methanol. 
         [0062]    Measuring method: 10 ul testing and standard solutions were respectively sucked with accuracy, injected into the HPLC and measured. 
         [0063]    The results were shown below. 
         [0000]    
       
         
               
             
               
               
               
               
             
           
               
                 TABLE 1 
               
             
             
               
                   
               
               
                 investigation of extracting  Radix Paeoniae alba  alone or in combination 
               
             
          
           
               
                   
                 Paeoniflorin content 
                   
                   
               
               
                 Process 
                 (mg/g) 
                 Yield rate (%) 
                 Dissolvability 
               
               
                   
               
               
                 1 st  process 
                 15.58 
                 20.63 
                 Totally dissolved, 
               
               
                   
                   
                   
                 good dissolvability 
               
               
                 2 nd  process 
                 15.10 
                 21.88 
                 Black residues, 
               
               
                   
                   
                   
                 somewhat less 
               
               
                   
                   
                   
                 dissolvability 
               
               
                   
               
             
          
         
       
     
         [0064]    As shown in the results, in terms of the paeoniflorin content, the extract prepared by extracting  Radix Paeoniae alba  alone was slightly higher than that in combination (3.18%). In terms of the yield rate, the former was less than the latter. In terms of the dissolvability, the former was much better than the latter. Compared with the latter one, the former process had advantages of shorter concentration heating time, less paeoniflorin loss, increased transfer rate, and elevated content in product. Thus, considering various factors comprehensively, the process by extracting  Radix Paeoniae alba  alone was reasonable. 
         [0065]    3. Investigation of extracting  Ramulus Uncariae cum Uncis  in different ways 
         [0066]    Rhynchophylline content and yield rate were used as indicators for investigation of extracting  Ramulus Uncariae cum Uncis  in different ways (where  Ramulus Uncariae cum Uncis  is decocted earlier or later). A mixture of  Radix Rehmanniae Preparata, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta, Ramulus Uncariae cum Uncis  and  Herba Asari  was taken at prescription dose. Production processes were designed respectively. 1 st  process was that aforesaid mixture was added with 6 fold of water, extracted for 3 times to have the extract, the first time for 2 hours, the second and third times for 1 hour. 2 nd  process was that  Radix Rehmanniae Preparata, Caulis Spatholobi, Spica Prunellae  and  Concha Margaritifera Usta  were added with 6 fold of water, extracted for 2 hours, filtered, and the resultant residues were mixed with the  Ramulus Uncariae cum Uncis,  extracted twice with 6 fold of water, each for 1 hour to have the extract. Rhynchophylline content and yield rate of afore-obtained extracts were measured respectively. 
         [0067]    Method for Determination of Rhynchophylline 
         [0068]    Apparatus and Reagent 
         [0069]    Agilent 1100 HPLC was equipped with quaternary pump, DAD, automatic sampler, online degasser and column thermostat. 
         [0070]    Standard rhynchophylline, methanol (chromatographically pure), purified water, triethylamine, glacial acetic acid (analytically pure) 
         [0071]    Chromatographic conditions: Agilent Zorbax SB-C 18  column (250 mm×4.6 mm, 5 μm) 
         [0072]    Mobile phase: methanol-10 mmol triethylamine solution (48:52), adjusted to pH=5.0 with acetic acid 
         [0073]    Flow rate: 1.0 ml/min; column temperature: 30° C.; detection wavelength: 254 nm 
         [0074]    Preparation of standard solution: appropriate quantity of standard rhynchophylline was taken and weighed accurately to prepare the standard solution (with lml solution containing 10 μg solute) by adding methanol. 
         [0075]    Preparation of testing solution: appropriate quantity (approximately equal to 2 g crude medicine  Ramulus Uncariae cum Uncis ) of combined water extract was sucked, alkalified by adding 5 ml ammonia water, extracted with chloroform for 3 times and combined, evaporated to dryness with water bath. The residues were dissolved by adding methanol to volume of 20 ml, filtered to give the testing solution. 
         [0076]    Measuring method: 10 μl testing and standard solutions were respectively sucked with accuracy, injected into the HPLC and measured. 
         [0077]    The results were shown below. 
         [0000]    
       
         
               
             
               
               
               
               
             
           
               
                 TABLE 2 
               
             
             
               
                   
               
               
                 investigation of extracting  Ramulus Uncariae cum Uncis  in different ways 
               
             
          
           
               
                   
                   
                 rhynchophylline content 
                   
               
               
                   
                 Process 
                 (mg) 
                 Yield rate (%) 
               
               
                   
                   
               
               
                   
                 1 st  process 
                 10.80 
                 13.39 
               
               
                   
                 2 nd  process 
                 10.92 
                 12.96 
               
               
                   
                   
               
             
          
         
       
     
         [0078]    As shown in the results, in terms of the rhynchophylline content, the extract prepared by 1 st  process was almost the same as that by 2 nd  process. In terms of the yield rate, the extract prepared by 1 st  process was slightly higher than that by 2 nd  process, but the difference was slight. The inconvenient operation brought by 2 nd  process should be considered, for example the medicine perhaps floated on the surface, which may influence extraction and cause potential safety hazard. Due to its simplified process, easy operation and enhanced safety, the 1 st  process was reasonable. 
         [0079]    As shown in pharmacological research, it is confirmed that said pharmaceutical composition has effects of ameliorating cerebral pial microcirculation, increasing cerebral blood flow, relaxing vasospasm and stopping pain. As shown in pharmacodynamics experiment, compared with the one prepared by methods known in prior arts, the pharmaceutical composition has an excellent effect of treating headache. 
       Embodiments  
     EXAMPLE 1 
       [0080]    The following medicinal materials were taken: 253.5 g of  Radix Angelicae Sinensis,  253.5 g of  Rhizoma Chuanxiong,  202.7 g of  Radix Paeoniae alba,  202.7 g of  Radix Rehmanniae Preparata,  506.8 g of  Ramulus Uncariae cum Uncis,  506.8 g of  Caulis Spatholobi,  506.8 g of  Spica Prunellae,  506.8 g of  Semen Cassiae,  506.8 g of  Concha Margaritifera Usta,  253.5 g of  Rhizoma Corydalis  and 50.5 g of  Herba Asari.    
         [0081]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% ethanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.300˜1.310 (74˜76° C.) to give 253 g of #1 Extract for later use. 
         [0082]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density is 1.23˜1.33 (65° C.) to give 42 g of #2 Extract for later use. 
         [0083]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 65˜70%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.320˜1.325 (79˜81° C.) to give 305 g of #3 Extract for later use. 
         [0084]    300 g of dextrin was dissolved with purified water, into which 3.0 g steviosin was added to dissolve by well stirring to give slurry. 600 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜45° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0085]    250.0 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 80˜90° C. to thoroughly dry. 
         [0086]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 4 g/bag. 
       EXAMPLE 2 
       [0087]    The following medicinal materials were taken: 338 g of  Radix Angelicae Sinensis,  338 g of  Rhizoma Chuanxiong,  270.3 g of  Radix Paeoniae alba,  270.3 g of  Radix Rehmanniae Preparata,  675.7 g of  Ramulus Uncariae cum Uncis,  675.7 g of  Caulis Spatholobi,  675.7 g of  Spica Prunellae,  675.7 g of  Semen Cassiae,  675.7 g of  Concha Margaritifera Usta,  338 g of  Rhizoma Corydalis  and 67.3 g of  Herba Asari.    
         [0088]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% ethanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.300˜1.310 (74˜76° C.) to give 335 g of #1 Extract for later use. 
         [0089]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.23˜1.33 (65° C.) to give 55 g of #2 Extract for later use. 
         [0090]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 65˜72%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.320˜1.325 (79˜81° C.) to give 420 g of #3 Extract for later use. 
         [0091]    83 g of sucrose was dissolved with purified water by well stirring to give the slurry. 810 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜45° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0092]    320 g rest of the sucrose was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0093]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 3 g/bag. 
       EXAMPLE 3 
       [0094]    The following medicinal materials were taken: 150 g of  Radix Angelicae Sinensis,  150 g of  Rhizoma Chuanxiong,  225 g of  Radix Paeoniae alba,  225 g of  Radix Rehmanniae Preparata,  551 g of  Ramulus Uncariae cum Uncis,  551 g of  Caulis Spatholobi,  551 g of  Spica Prunellae,  551 g of  Semen Cassiae,  551 g of  Concha Margaritifera Usta,  225 g of  Rhizoma Corydalis  and 19 g of  Herba Asari.    
         [0095]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 5 fold of 70% ethanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.250˜1.310 (70˜74° C.) to give 210 g of #1 Extract for later use. 
         [0096]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 80% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.15˜1.25 (65° C.) to give 50 g of #2 Extract for later use. 
         [0097]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 60˜65%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.27˜1.320 (75˜80° C.) to give 545 g of #3 Extract for later use. 
         [0098]    231 g of dextrin was dissolved with purified water, into which 3.0 g steviosin was added to dissolve by well stirring to give the slurry. 805 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0099]    151 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0100]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 4 g/bag. 
       EXAMPLE 4 
       [0101]    The following medicinal materials were taken: 250 g of  Radix Angelicae Sinensis,  250 g of  Rhizoma Chuanxiong,  250 g of  Radix Paeoniae alba,  250 g of  Radix Rehmanniae Preparata,  740 g of  Ramulus Uncariae cum Uncis,  740 g of  Caulis Spatholobi,  740 g of  Spica Prunellae,  740 g of  Semen Cassiae,  740 g of  Concha Margaritifera Usta,  250 g of  Rhizoma Corydalis  and 50 g of  Herba Asari.    
         [0102]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 80% ethanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.300˜1.350 (75˜80° C.) to give 300 g of #1 Extract for later use. 
         [0103]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 6 fold of 60% ethanol, soaked, extracted by using heating refluxing for 3 times, the first time for 3 hours and the second time for 1 hour and the third time for 0.5 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.20˜1.35 (60° C.) to give 60 g of #2 Extract for later use. 
         [0104]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 8 fold of water, the first time for 3 hours and the second time for 2 hours, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 80˜85%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.30˜1.350 (80˜85° C.) to give 425 g of #3 Extract for later use. 
         [0105]    80 g of soluble starch was dissolved with purified water, into which 3 g steviosin was added to dissolve by well stirring to give the slurry. 785 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0106]    330 g rest of the soluble starch was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0107]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 3 g/bag. 
       EXAMPLE 5 
       [0108]    The following medicinal materials were taken: 338 g of  Radix Angelicae Sinensis,  338 g of  Rhizoma Chuanxiong,  75 g of  Radix Paeoniae alba,  75 g of  Radix Rehmanniae Preparata,  510 g of  Ramulus Uncariae cum Uncis,  510 g of  Caulis Spatholobi,  510 g of  Spica Prunellae,  510 g of  Semen Cassiae,  510 g of  Concha Margaritifera Usta,  337 g of  Rhizoma Corydalis  and 37 g of  Herba Asari.    
         [0109]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 50% ethanol, the first time for 2 hours and the second time for 2 hours, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.300˜1.350 (73˜78° C.) to give 330 g of #1 Extract for later use. 
         [0110]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 5 fold of 70% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 1 hour and the second time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.23˜1.35 (65° C.) to give 15 g of #2 Extract for later use. 
         [0111]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 10 fold of water, the first time for 2 hours and the second time for 2 hours, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 63˜70%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.290˜1.330 (78˜83° C.) to give 253 g of #3 Extract for later use. 
         [0112]    320 g of dextrin was dissolved with purified water, into which 3 g steviosin was added to dissolve by well stirring to give the slurry. 598 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0113]    240 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0114]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 4 g/bag. 
       EXAMPLE 6 
       [0115]    The following medicinal materials were taken: 300 g of  Radix Angelicae Sinensis,  300 g of  Rhizoma Chuanxiong,  400 g of  Radix Paeoniae alba,  400 g of  Radix Rehmanniae Preparata,  650 g of  Ramulus Uncariae cum Uncis,  650 g of  Caulis Spatholobi,  650 g of  Spica Prunellae,  650 g of  Semen Cassiae,  650 g of  Concha Margaritifera Usta,  300 g of  Rhizoma Corydalis  and 50 g of  Herba Asari.    
         [0116]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 3 times with 3 fold of 60% ethanol, the first time for 2 hours, the second time for 1 hour and the third time for 0.5 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.29˜1.340 (73˜78° C.) to give 315 g of #1 Extract for later use. 
         [0117]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 80% ethanol, soaked, extracted by using heating refluxing for 3 times, the first time for 2 hours, the second time for 1 hour and the third time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.18˜1.33 (65° C.) to give 90 g of #2 Extract for later use. 
         [0118]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 7 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 70˜75%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.310˜1.330 (77˜82° C.) to give 375 g of #3 Extract for later use. 
         [0119]    84 g of dextrin was dissolved with purified water, into which 3 g steviosin was added to dissolve by well stirring to give the slurry. 780 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0120]    336 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0121]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 3 g/bag. 
       EXAMPLE 7 
       [0122]    The following medicinal materials were taken: 338 g of  Radix Angelicae Sinensis,  338 g of  Rhizoma Chuanxiong,  300 g of  Radix Paeoniae alba,  300 g of  Radix Rehmanniae Preparata,  413 g of  Ramulus Uncariae cum Uncis,  413 g of  Caulis Spatholobi,  413 g of  Spica Prunellae,  413 g of  Semen Cassiae,  413 g of  Concha Margaritifera Usta,  337 g of  Rhizoma Corydalis  and 75 g of  Herba Asari.    
         [0123]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 6 fold of 70% ethanol, the first time for 2 hours and the second time for 0.5 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.260˜1.310 (74˜76° C.) to give 300 g of #1 Extract for later use. 
         [0124]    Preparation of #2 Extract: Radix Paeoniae alba was added with 6 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 2 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.21˜1.34 (55° C.) to give 70 g of #2 Extract for later use. 
         [0125]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 6 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 65˜75%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.300˜1.300 (79˜81° C.) to give 424 g of #3 Extract for later use. 
         [0126]    40 g of dextrin was dissolved with purified water, into which 3 g steviosin was added to dissolve by well stirring to give the slurry. 794 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0127]    163 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0128]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 4 g/bag. 
       EXAMPLE 8 
       [0129]    The following medicinal materials were taken: 450 g of  Radix Angelicae Sinensis,  450 g of  Rhizoma Chuanxiong,  350 g of  Radix Paeoniae alba,  350 g of  Radix Rehmanniae Preparata,  570 g of  Ramulus Uncariae cum Uncis,  570 g of  Caulis Spatholobi,  570 g of  Spica Prunellae,  570 g of  Semen Cassiae,  570 g of  Concha Margaritifera Usta,  450 g of  Rhizoma Corydalis  and 100 g of  Herba Asari.    
         [0130]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 6 fold of 80% ethanol, the first time for 1 hour and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.29˜1.340 (73˜78° C.) to give 390 g of #1 Extract for later use. 
         [0131]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 3 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2.5 hours and the second time for 2 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.17˜1.33 (65° C.) to give 65 g of #2 Extract for later use. 
         [0132]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 9 fold of water, the first time for 3 hours and the second time for 3 hours, filtered, concentrated until the relative density was 1.06˜1.08 (80° C.), into which ethanol was added to make a final ethanol content of 65˜75%, left to stand still for 12˜22 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.310˜1.330 (77˜82° C.) to give 385 g of #3 Extract for later use. 
         [0133]    110 g of dextrin was dissolved with purified water, into which 3 g steviosin was added to dissolve by well stirring to give the slurry. 840 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0134]    256 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0135]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 3 g/bag. 
       EXAMPLE 9 
       [0136]    The following medicinal materials were taken: 253.5 g of  Radix Angelicae Sinensis,  253.5 g of  Rhizoma Chuanxiong,  202.7 g of  Radix Paeoniae alba,  202.7 g of  Radix Rehmanniae Preparata,  506.8 g of  Ramulus Uncariae cum Uncis,  506.8 g of  Caulis Spatholobi,  506.8 g of  Spica Prunellae,  506.8 g of  Semen Cassiae,  506.8 g of  Concha Margaritifera Usta,  253.5 g of  Rhizoma Corydalis  and 50.5 g of  Herba Asari.    
         [0137]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% ethanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.250˜1.310 (70˜74° C.) to give 253 g of #1 Extract for later use. 
         [0138]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.23˜1.33 (65° C.) to give 42 g of #2 Extract for later use. 
         [0139]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 65˜75%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.27˜1.320 (75˜80° C.) to give 305 g of #3 Extract for later use. 
         [0140]    300 g of soluble starch was dissolved with purified water, into which 3.0 g steviosin was added to dissolve by well stirring to give the slurry. 600 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0141]    250.0 g rest of the soluble starch was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 80˜90° C. to thoroughly dry. 
         [0142]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 4 g/bag. 
       EXAMPLE 10 
       [0143]    The following medicinal materials were taken: 338 g of  Radix Angelicae Sinensis,  338 g of  Rhizoma Chuanxiong,  270.3 g of  Radix Paeoniae alba,  270.3 g of  Radix Rehmanniae Preparata,  675.7 g of  Ramulus Uncariae cum Uncis,  675.7 g of  Caulis Spatholobi,  675.7 g of  Spica Prunellae,  675.7 g of  Semen Cassiae,  675.7 g of  Concha Margaritifera Usta,  338 g of  Rhizoma Corydalis  and 67.3 g of  Herba Asari.    
         [0144]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 70% ethanol, the first time for 2 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.280˜1.320 (75˜80° C.) to give 335 g of #1 Extract for later use. 
         [0145]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 60% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 1 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.23˜1.33 (65° C.) to give 55 g of #2 Extract for later use. 
         [0146]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 60˜65%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.315˜1.320 (76˜79° C.) to give 420 g of #3 Extract for later use. 
         [0147]    80 g of microcrystalline cellulose was dissolved with purified water, into which 3.0 g aspartame was added to dissolve by well stirring to give the slurry. 810 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0148]    320 g rest of the microcrystalline cellulose was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0149]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 3 g/bag. 
       EXAMPLE 11 
       [0150]    The following medicinal materials were taken: 150 g of  Radix Angelicae Sinensis,  150 g of  Rhizoma Chuanxiong,  225 g of  Radix Paeoniae alba,  225 g of  Radix Rehmanniae Preparata,  551 g of  Ramulus Uncariae cum Uncis,  551 g of  Caulis Spatholobi,  551 g of  Spica Prunellae,  551 g of  Semen Cassiae,  551 g of  Concha Margaritifera Usta,  225 g of  Rhizoma Corydalis  and 19 g of  Herba Asari.    
         [0151]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 5 fold of 70% ethanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.290˜1.300 (75˜77° C.) to give 210 g of #1 Extract for later use. 
         [0152]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 4 fold of 80% ethanol, soaked, extracted by using heating refluxing for 2 times, the first time for 2 hours and the second time for 2 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.15˜1.25 (65° C.) to give 50 g of #2 Extract for later use. 
         [0153]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 5 fold of water, the first time for 2 hours and the second time for 1 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 65˜70%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.310˜1.315 (79˜82° C.) to give 545 g of #3 Extract for later use. 
         [0154]    231 g of lactose was dissolved with purified water, into which 3.0 g aspartame was added to dissolve by well stirring to give the slurry. 805 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0155]    151 g rest of the lactose was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0156]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 4 g/bag. 
       EXAMPLE 12 
       [0157]    The following medicinal materials were taken: 250 g of  Radix Angelicae Sinensis,  250 g of  Rhizoma Chuanxiong,  250 g of  Radix Paeoniae alba,  250 g of  Radix Rehmanniae Preparata,  740 g of  Ramulus Uncariae cum Uncis,  740 g of  Caulis Spatholobi,  740 g of  Spica Prunellae,  740 g of  Semen Cassiae,  740 g of  Concha Margaritifera Usta,  250 g of  Rhizoma Corydalis  and 50 g of  Herba Asari.    
         [0158]    Preparation of #1 Extract:  Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Corydalis  and  Semen Cassiae  were mixed, extracted by using heating refluxing for 2 times with 4 fold of 80% ethanol, the first time for 2.5 hours and the second time for 1 hour, and filtered to remove the impurities; and the ethanol was recovered and concentrated until the relative density was 1.280˜1.300 (75˜77° C.) to give 300 g of #1 Extract for later use. 
         [0159]    Preparation of #2 Extract:  Radix Paeoniae alba  was added with 6 fold of 60% ethanol, soaked, extracted by using heating refluxing for 3 times, the first time for 2 hours, the second time for 1 hour and the third time for 0.5 hour, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.20˜1.35 (60° C.) to give 60 g of #2 Extract for later use. 
         [0160]    Preparation of #3 Extract:  Radix Rehmanniae Preparata, Ramulus Uncariae cum Uncis, Caulis Spatholobi, Spica Prunellae, Concha Margaritifera Usta  and  Herba Asari  were mixed, decocted for 2 times with 8 fold of water, the first time for 3 hours and the second time for 2 hour, filtered, concentrated until the relative density was 1.06˜1.10 (80° C.), into which ethanol was added to make a final ethanol content of 80˜85%, left to stand still for 12˜24 hours, and filtered; and the ethanol was recovered and concentrated until the relative density was 1.280˜1.330 (75˜80° C.) to give 425 g of #3 Extract for later use. 
         [0161]    80 g of dextrin was dissolved with purified water, into which 3 g aspartame was added to dissolve by well stirring to give the slurry. 785 g of well-prepared three Extracts were added into the slurry and stirred stepwise. The density of resultant slurry was adjusted to 1.12˜1.23 (42˜50° C.), and the slurry was online filtered with 60˜100 mesh sifter. 
         [0162]    330 g rest of the dextrin was put into the granulator. A series of parameters were adjusted, e.g. fan frequency, temperature of inlet air, frequency of liquid feed and spray pressure, to make materials in well-fluidized state in the fluid bed. The materials were spray-granulated at a temperature of 30˜60° C., and dried. The temperature was further increased to 70˜90° C. to thoroughly dry. 
         [0163]    The resultant granules were sorted, sifted and totally mixed to produce granules. The package was aluminum-plastic composite film pillow bag with specification of 3 g/bag. 
         [0164]    Beneficial effects of said pharmaceutical compositions on treating headache have been demonstrated by following 2 pharmacodynamic researches. 
         [0165]    Pharmacodynamic Research 1. Ameliorating Effect of Pharmaceutical Composition (YXQN) on Nitroglycerin-Induced Migraine in Rats 
         [0166]    1. Materials 
         [0167]    1.1 Animals: SD rats, male, weighing 180-200 g were provided by Beijing Weitonglihua Experimental Animal Technology Co., Ltd. The animals were raised in separate cages under natural light with excellent ventilation and free access to water and food. Animal diet was pellet feed purchased from Jinan Dakang Feed Inc. (Certificate No.: 364). Feeding environment for test animals was in accordance with the  Regulation of Test Animals Tianjin.    
         [0168]    1.2 Drug: tested drug was prepared by the method of Example 1 (YXQN-1), and comparison drug by the method of Chinese patent ZL200510073290.3 (YXQN-2). Both were provided by Tasly Pharmaceutical Co., Ltd. Qiyeanshen tablet (Approval. No.: Z45022054), as a positive control drug, was produced by Guangxi Beihai Pharmaceutical Co., Ltd (LOT: 20130123). Daily dosage: 20 mg per day. 
         [0169]    1.3 Reagent: NOS assay kit, Coomassie brilliant blue protein assay kit and NO assay kit were purchased from Nanjing Jiancheng Science &amp; technology Co., Ltd (LOT:20120726), Rat 5-HT kit was purchased from Shanghai Jianglai Bio-tech Co., Ltd (LOT:12-05), ELISA kit was purchased from Shanghai Meilian Bio-tech Co., Ltd and rat DA ELISA kit was purchased from Shanghai Kaibo Bio-tech Co., Ltd. Normal saline and 10% chloral hydrate. 
         [0170]    1.4 Apparatus: Shimadzu UV2100 ultraviolet spectrophotometer, FLUKO F6/10 high-shearing dispersion emulsifier, Hettich ROTANTA 460R high-speed refrigerated centrifuge, Electronic balance and ultrasound Doppler blood stream detector. 
         [0171]    2. Method 
         [0172]    2.1 Grouping and Administration 
         [0173]    Animals were randomly divided into 9 groups according to body weight, 10 rats in each group: the model group; positive control group; blank control group; high, middle and low dosage groups of YXQN-1 (1.562 g, 0.781 g and 0.391 extract/kg respectively); high, middle and low dosage groups of YXQN-2 (1.562 g, 0.781 g and 0.391 extract/kg respectively). Preventively, YXQN-1, YXQN-2 and positive control groups were administrated for 10 consecutive days. Positive drug was given at a dosage of 20 mg per day. Equal volume of normal saline was intragastrically administrated to model group and blank control group. 
         [0174]    2.2 Establishment of Behavior Observation Model 
         [0175]    Except the blank control group, remaining rats received subcutaneous injection of nitroglycerin (10 ml/kg). Experimental migrainous rat models were duplicated. After administrated intragastrically, those rats, having two reddish ears and increased frequency of scratching head with forepaws, were taken as successful modeling. (1) Reddish ear: to observe the time the reddish ear appeared and disappeared after modeling; (2) Scratching head: to observe the frequency of scratching head every 30 min after modeling, the time scratching head appeared with consecutive scratching head for 5 times or more as the symbol, and the time scratching head disappeared with scratching head of less than 5 times during an interval, depression and fatigue as the symbol. 
         [0176]    2.3 Determination of Bio-Marker 
         [0177]    All animal models were made and administrated in light of aforesaid method. Blood and brain were collected 4 hours after modeling to prepare blood and brain homogenates, and frozen reserved for later use. Method of chemical colorimetry was performed in accordance with the label of the kit to assay NO content and NOS activity in serum; as well as 5-HT, 5-HIAA, NA DA contents in brain. 
         [0178]    2.4 Statistical Management 
         [0179]    All data were analyzed with SPSS 20.0 software, results were expressed as  x ±s and t-test was used between groups. 
         [0180]    3. Results 
         [0181]    3.1 Reddish Ears 
         [0182]    No reddish ear was observed in blank control group. Reddish ears appeared in YXQN-1, YXQN-2 and model group 3 min after modeling. Compared with the model group, there was no significant difference in the time reddish ears appeared. After treatment, compared with the model group, the time reddish ears disappeared in middle and low dosage groups of YXQN-1 had statistical significance (P&lt;0.05, P&lt;0.01), however, no significant difference was found in the YXQN-2 groups. Compared with the equal dosage group of YXQN-2, the high and middle dosage groups of YXQN-1 had significant difference (P&lt;0.05). The results were shown in Table 3. 
         [0000]    
       
         
               
             
               
               
               
               
             
           
               
                 TABLE 3 
               
             
             
               
                   
               
               
                 effect of YXQN-1 and YXQN-2 on the time reddish ears appeared and 
               
               
                 disappeared in rats (min,  x  ± s) 
               
             
          
           
               
                   
                   
                 Reddish ear appeared 
                 Reddish ear 
               
               
                 Groups 
                 n 
                 (min) 
                 disappeared (min) 
               
               
                   
               
               
                 Blank control group 
                 10 
                 0 
                 0 
               
               
                 Model group 
                 10 
                 3.28 ± 0.21 
                 187.26 ± 10.44 
               
               
                 Qiyeanshen Tablet 
                 10 
                 3.66 ± 0.50 
                 109.45 ± 14.22* 
               
               
                 YXQN-1 (High) 
                 10 
                 3.55 ± 0.72 
                  99.26 ± 15.28# 
               
               
                 YXQN-1 (Middle) 
                 10 
                 3.44 ± 0.52 
                 111.87 ± 9.92**# 
               
               
                 YXQN-1 (Low) 
                 10 
                 3.15 ± 0.33 
                 126.95 ± 9.10* 
               
               
                 YXQN-2 (High) 
                 10 
                 3.29 ± 0.60 
                 125.49 ± 13.19 
               
               
                 YXQN-2 (middle) 
                 10 
                 3.83 ± 0.86 
                 135.99 ± 10.11 
               
               
                 YXQN-2 (Low) 
                 10 
                 3.55 ± 0.19 
                 138.95 ± 12.22 
               
               
                   
               
               
                 Compared with the model group, *P &lt; 0.05, **P &lt; 0.01; 
               
               
                 compared with YXQN-2, #P &lt; 0.05. 
               
             
          
         
       
     
         [0183]    3.2 Frequency of Scratching Head 
         [0184]    In the blank control group, scratching head occasionally appeared once or twice during a few period of time. At about 3 rd  min after modeling, scratching head appeared in YXQN-1, YXQN-2 and model groups, having no statistical significance, as compared with the model group. After treatment, there were more times of scratching head during period of 0 th ˜30 th  min and 30 th ˜60 th  min. Compared with the model group, the high, middle and low dosage groups of YXQN-1 had statistical significance (P&lt;0.05, P&lt;0.01) in frequency of scratching head. The significant difference had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant difference (P&lt;0.05). The results were shown in Table 4. 
         [0000]    
       
         
               
             
               
               
               
               
               
             
           
               
                 TABLE 4 
               
             
             
               
                   
               
               
                 effect of YXQN-1 and YXQN-2 on the frequency of scratching head in 
               
               
                 rats (  x  ± s) during each period of time 
               
             
          
           
               
                   
                   
                   
                 Frequency 
                 Frequency 
               
               
                   
                 Group 
                 N 
                 (0~30 min) 
                 (30~60 min) 
               
               
                   
                   
               
               
                   
                 Blank control group 
                 10 
                 0 
                 0 
               
               
                   
                 Model group 
                 10 
                 17.9 ± 1.1 
                 86.4 ± 17.1 
               
               
                   
                 Qiyeanshen Tablet 
                 10 
                  6.1 ± 2.0** 
                 30.4 ± 2.7* 
               
               
                   
                 YXQN-1 (High) 
                 10 
                 10.4 ± 2.9** 
                 26.9 ± 5.1** 
               
               
                   
                 YXQN-1 (Middle) 
                 10 
                 12.1 ± 1.5*# 
                 37.3 ± 3.7*# 
               
               
                   
                 YXQN-1 (Low) 
                 10 
                 13.3 ± 1.6*# 
                 49.6 ± 3.6*# 
               
               
                   
                 YXQN-2 (High) 
                 10 
                 12.5 ± 2.4 
                 45.9 ± 4.1 
               
               
                   
                 YXQN-2 (middle) 
                 10 
                 15.3 ± 2.5 
                 50.2 ± 5.6 
               
               
                   
                 YXQN-2 (Low) 
                 10 
                 16.3 ± 2.8 
                 55.5 ± 2.9 
               
               
                   
                   
               
               
                   
                 Compared with the model group, *P &lt; 0.05, **P &lt; 0.01; 
               
               
                   
                 compared with YXQN-2, #P &lt; 0.05. 
               
             
          
         
       
     
         [0185]    3.3 Level of NO and NOS in Serum 
         [0186]    Compared with the model group, the serum level of NO and NOS in rats in the high, middle and low dosage groups of YXQN-1 had statistical significance (P&lt;0.05, P&lt;0.01). The significant difference had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant difference (P&lt;0.05). The results were shown in Table 5. 
         [0000]    
       
         
               
             
               
               
               
               
             
           
               
                 TABLET 5 
               
             
             
               
                   
               
               
                 effect of YXQN-1 and YXQN-2 on the serum level of NO and NOS in 
               
               
                 rats (  x  ± s) 
               
             
          
           
               
                 Group 
                 N 
                 NO (μmol/L) 
                 NOS (U/ml) 
               
               
                   
               
               
                 Blank control group 
                 10 
                  30.64 ± 11.18 
                 20.84 ± 1.89 
               
               
                 Model group 
                 10 
                 130.21 ± 11.39 
                 47.84 ± 1.91 
               
               
                 Qiyeanshen Tablet 
                 10 
                  78.13 ± 18.16** 
                 28.78 ± 3.75* 
               
               
                 YXQN-1 (High) 
                 10 
                  83.76 ± 17.94** 
                 45.19 ± 4.28** 
               
               
                 YXQN-1 (Middle) 
                 10 
                  96.10 ± 11.73*# 
                  47.3 ± 2.28*# 
               
               
                 YXQN-1 (Low) 
                 10 
                 107.72 ± 15.9*# 
                 49.31 ± 1.53*# 
               
               
                 YXQN-2 (High) 
                 10 
                  97.33 ± 16.23 
                 48.22 ± 4.28 
               
               
                 YXQN-2 (middle) 
                 10 
                 101.11 ± 19.01 
                  50.2 ± 5.6 
               
               
                 YXQN-2 (Low) 
                 10 
                 118.72 ± 18.75 
                  55.5 ± 2.9 
               
               
                   
               
               
                 Compared with the model group, *P &lt; 0.05, **P &lt; 0.01; 
               
               
                 compared with YXQN-2, #P &lt; 0.05. 
               
             
          
         
       
     
         [0187]    3.4 Contents of 5-HT, 5-HIAA and DA 
         [0188]    Compared with the model group, the contents of 5-HT, 5-HIAA and DA in rats in the high, middle and low dosage groups of YXQN-1 had statistical significance (P&lt;0.05, P&lt;0.01). The significant difference had not yet been found in each dosage group of the YXQN-2. In terms of 5-HT and 5-HIAA, compared with the equal dosage group of YXQN-2, the middle and low dosage groups of YXQN-1 had significant difference (P&lt;0.05). In terms of DA, compared with the equal dosage group of YXQN-2, the middle and high dosage groups of YXQN-1 had significant difference (P&lt;0.05). The results were shown in Table 6. 
         [0000]    
       
         
               
             
               
               
               
               
               
             
           
               
                 TABLE 6 
               
             
             
               
                   
               
               
                 effect of YXQN-1 and YXQN-2 on the contents of 5-HT, 5-HIAA and DA in 
               
               
                 rats (  x  ± s) 
               
             
          
           
               
                 Group 
                 n 
                 5-HT (ng/g) 
                 5-HIAA (mg/d) 
                 DA (ng/L) 
               
               
                   
               
               
                 Blank control group 
                 10 
                 201.7 ± 7.8 
                 125.23 ± 11.22 
                 49.33 ± 10.51 
               
               
                 Model group 
                 10 
                 126.6 ± 7.8 
                 247.48 ± 1.10 
                 65.16 ± 12.90 
               
               
                 Qiyeanshen Tablet 
                 10 
                  185.3 ± 6.1* 
                 129.65 ± 3.10* 
                 54.04 ± 11.27 
               
               
                 YXQN-1 (High) 
                 10 
                  185.2 ± 2.8* 
                 130.19 ± 24.28** 
                 56.01 ± 11.51*# 
               
               
                 YXQN-1 (Middle) 
                 10 
                  171.9 ± 3.3*# 
                  139.3 ± 22.28*# 
                 59.11 ± 10.85*# 
               
               
                 YXQN-1 (Low) 
                 10 
                  158.3 ± 4.6*# 
                 149.31 ± 1.53*# 
                 61.08 ± 10.51* 
               
               
                 YXQN-2 (High) 
                 10 
                 170.3 ± 6.3 
                 158.22 ± 34.20 
                 59.67 ± 10.32 
               
               
                 YXQN-2 (middle) 
                 10 
                 145.1 ± 9.1 
                 168.20 ± 25.60 
                 61.28 ± 14.32 
               
               
                 YXQN-2 (Low) 
                 10 
                 120.72 ± 8.5  
                  155.5 ± 23.90 
                 61.54 ± 15.20 
               
               
                   
               
             
          
         
       
     
         [0189]    4. Conclusion 
         [0190]    Said pharmaceutical composition of present invention may ameliorate nitroglycerin-induced behavioral indices and biochemical indices in models of migraine rats. As shown in the research, said pharmaceutical composition of present invention is proven to have an effect on ameliorating nitroglycerin-induced behavioral indices in models of migraine rats, which is better than the comparison drug. 
         [0191]    Pharmacodynamic Research 2. Effect of Pharmaceutical Composition (YXQN) on Change of Cerebral Blood Flow in Model of Migraine Rabbits 
         [0192]    1. Materials 
         [0193]    1.1 Commercially available 36 rabbits, weighing 2.2±0.5 kg, were randomly divided into 6 groups, 6 rabbits in each group. The animals were raised in laboratory of basic medicine college of Tianjin Medical University, under natural light with excellent ventilation and free access to water and food. 
         [0194]    1.2 Drugs: tested drug was prepared by the method of Example 1 (YXQN-1), and comparison drug was prepared by the method of Chinese patent ZL200510073290.3 (YXQN-2). Both were provided by Tasly Pharmaceutical Co., Ltd. 
         [0195]    1.3 Apparatus: ultrasound Doppler blood stream detector 
         [0196]    2. Method 
         [0197]    2.1 Grouping and administration 
         [0198]    Animals were randomly divided into 6 groups according to body weight, 6 rabbits in each group: the model group; blank control group; high, and low dosage groups of YXQN-1 (0.782 g and 0.391 g extract/kg respectively); high and low dosage groups of YXQN-2 (0.782 g and 0.391 g extract/kg respectively). The model and blank control groups were administrated by gastric perfusion with equal volume of normal saline. Animal modeling method was the same as aforesaid Pharmacodynamic Research 1. Except treatment by drugs, the model group was administrated by ear vein injection of 5-HT (2 mg/kg) for consecutive 3 days, and at 3 rd  day Diazepam injection (7.5 mg/rabbit) was added. Cerebral blood flow was assayed 30 min after the last administration. The rabbits were fixed in rabbit hutch. 2 MHz detector was used on the temporal to detect, with a sampling volume of 7 mm and a depth of 26±2 mm. 
         [0199]    2. Statistical Management 
         [0200]    All results were expressed as  x ±s and t-test was used between groups. 
         [0000]      PI=2×( Vs−Vd )/( Vs+Vd )
 
         [0201]    PI: pulse index 
         [0202]    Vs: blood flow velocity of contraction peak 
         [0203]    Vd: blood flow velocity of diastole end 
         [0204]    Vm: mean blood flow velocity 
         [0205]    3. Results 
         [0206]    3.1 Vs, Vd, Vm and PI 
         [0207]    Blood flow velocity in the blank control group remained unchanged. After modeling, the blood flow velocities in YXQN-1, YXQN-2 and model groups were decreased, having no statistical significance, as compared with the model group. After treatment, compared with the model group, the high and low dosage groups of YXQN-1 had statistical significance (P&lt;0.05, P&lt;0.01). The significant difference had not yet been found in each dosage group of the YXQN-2. Compared with the equal dosage group of YXQN-2, the high dosage group of YXQN-1 had significant difference (P&lt;0.05). The results were shown in Table 7. 
         [0000]    
       
         
               
             
               
               
               
               
               
               
             
           
               
                 TABLET 7 
               
             
             
               
                   
               
               
                 effect of YXQN-1 and YXQN-2 on the change of cerebral blood flow in 
               
               
                 rabbits (  x  ± s) 
               
             
          
           
               
                   
                   
                   
                   
                 Vm 
                   
               
               
                 Group 
                 n 
                 Vs (cm/s) 
                 Vd (cm/s) 
                 (cm/s) 
                 PI 
               
               
                   
               
               
                 Blank control group 
                 6 
                 43.53 ± 4.8 
                 40.33 ± 3.22 
                 41.56 ± 3.51 
                 0.082 ± 0.001 
               
               
                 Model group 
                 6 
                 24.71 ± 4.54 
                 19.48 ± 3.10 
                 21.16 ± 2.90 
                 0.23 ± 0.03 
               
               
                 YXQN-1 (high) 
                 6 
                 39.23 ± 5.84* 
                 34.34 ± 4.98** 
                 35.01 ± 4.23 
                 0.22 ± 0.03 
               
               
                 YXQN-1 (low) 
                 6 
                 38.33 ± 4.63*# 
                 33.76 ± 4.96*# 
                 34.08 ± 3.51 
                 0.21 ± 0.03 
               
               
                 YXQN-2 (high) 
                 6 
                 30.22 ± 4.31 
                 28.13 ± 4.20 
                 30.55 ± 5.32 
                 0.23 ± 0.03 
               
               
                 YXQN-2 (low) 
                 6 
                 29.18 ± 5.5 
                 27.99 ± 4.90 
                 27.34 ± 4.20 
                 0.21 ± 0.03 
               
               
                   
               
             
          
         
       
     
         [0208]    4. Conclusion 
         [0209]    Said pharmaceutical composition of present invention may ameliorate change of cerebral blood flow in model of migraine rabbits. As shown in this research, said pharmaceutical composition could improve the nitroglycerin-induced change of cerebral blood flow in migraine rabbits, which was better than the comparison drug.